The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer

Clinical Nuclear Medicine - United States
doi 10.1097/rlu.0b013e31824437b3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Local-Regional Control According to Surrogate Markers of Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast Conserving Therapy

Breast Cancer Research
Cancer ResearchOncology
2012English

Noninvasive Subharmonic Pressure Estimation for Monitoring Breast Cancer Response to Neoadjuvant Therapy

2013English

Neoadjuvant Systemic Therapy in Breast Cancer

2012English

Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

Response to Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Use of Dynamic Contrast-Enhanced MR Imaging to Predict Survival in Patients With Primary Breast Cancer Undergoing Neoadjuvant Chemotherapy

Radiology
Nuclear MedicineRadiologyImaging
2011English

MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response After Neoadjuvant Therapy

Radiology
Nuclear MedicineRadiologyImaging
2018English

Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

[18f]ml-10 PET Imaging Fails to Assess Early Response to Neoadjuvant Chemotherapy in a Preclinical Model of Triple Negative Breast Cancer

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy